NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DC-24-025 from the NIH Guide for Grants and Contracts
Notice NOT-EB-24-005 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-083 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-24-011 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of clinical research platforms that will enable future clinical trials to determine whether combinations of HIV cure strategies can be effective when optimally tailored to the participants. The ultimate goal is for the results of such proof-of-concept clinical studies to inform the development and prioritization of more broad-based curative strategies that will be effective in all people living with HIV. This NOFO will support multidisciplinary teams to conduct coordinated basic and pre-clinical research to profile participants intact, rebound-competent HIV reservoirs and immunologic backgrounds and use that information to develop and test combinations of HIV curative approaches that are specifically tailored to those participants.
Notice NOT-HL-24-008 from the NIH Guide for Grants and Contracts
Notice NOT-GM-24-029 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-RM-24-002 from the NIH Guide for Grants and Contracts. The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To support innovative and novel research across the vast NIH mission, individuals from diverse backgrounds (including those from underrepresented groups; see Notice of NIHs Interest in Diversity) and from the full spectrum of eligible institutions in all geographic locations are encouraged to apply to this Notice of Funding Opportunity. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.
Notice NOT-NR-24-009 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AT-24-007 from the NIH Guide for Grants and Contracts. The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit limited applications for continuation of an established nuclear magnetic resonance (NMR) research resource consisting of raw and meta-data from natural products ranging from crude extracts to purified substances; with the capacity to upload, download, store, search and analyze raw NMR data. The purpose of this limited competition is to promote sustainability, scaling and wider community inclusiveness of the established NMR research resource. This notice of funding opportunity (NOFO) is part of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include the Botanical Dietary Supplements Translational Research Teams (RM1) and Leveraging Big Data to Understand Natural Product Impacts on Whole Person Health (R01).
Notice NOT-MD-24-011 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-25-004 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to participate in a research program cooperative agreement to support theOptimizing Health of Children and Adolescents with Perinatal HIV Exposure Initiative. The objective of this NOFO is to generate information needed to develop and to test interventions for the early detection and reduction of long-term effects of in utero/perinatal exposure toantiretroviral therapy (ART) and/or HIV among individuals who are HIV exposed but uninfected (IHEU).Investigators with innovative thinking and new approaches to address the public health issues facing IHEUs are encouraged to apply.
Notice NOT-AA-24-007 from the NIH Guide for Grants and Contracts
Notice NOT-AA-24-008 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-026 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-027 from the NIH Guide for Grants and Contracts
Notice NOT-DK-24-014 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-080 from the NIH Guide for Grants and Contracts
Notice NOT-DA-24-019 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-024 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-24-016 from the NIH Guide for Grants and Contracts. Reissue: RFA-NS-21-023 - The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.